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  Just six years ago, two draft versions of 
the human genome were published, an 
achievement widely hailed as one of the 
most audacious scientiﬁ  c undertakings 
in history. Both of these versions are 
composite sequences derived from 
the haploid genomes—the single set 
of 23 chromosomes packaged into 
the sperm or egg of each parent—of 
(mostly) anonymous donors. But 
now, one of the principals behind the 
private human genome initiative has 
taken the next logical, albeit risky, step: 
sequencing his own genome. J. Craig 
Venter, whose technical innovations 
at Celera helped complete the draft 
sequences far ahead of schedule, 
published his entire genome in 
collaboration with 30 colleagues in this 
issue of PLoS Biology.
    By placing his genome in the 
public domain, Venter runs the risk 
of divulging intimate personal details, 
including any current and future 
genetic markers for disease—a risk that 
extends to his family. He has done so, 
in part, to stimulate efforts to develop 
cheaper sequencing technology and 
usher in a new era of individualized 
genomic medicine. Venter has been 
working with the X Prize Foundation, 
which has promised US$10 million 
to the ﬁ  rst person who can sequence 
a genome for US$1,000. Having the 
complete sequence of an individual 
human being will also allow scientists 
to ask different questions about the 
nature and origin of human genetic 
variation.
    James Watson, the original director 
of the Human Genome Project 
and now chancellor of Cold Spring 
Harbor Laboratory, has also allowed 
his genome to be sequenced. He 
received a DVD documenting his 
personal sequence in a ceremony at 
Baylor College of Medicine in May 
2007. (The report on his genome had 
not been published at press time.) 
With these sequences, scientists 
have a powerful tool for exploring 
the genetic contribution to human 
biology and disease risk. For example, 
the International HapMap Project 
maintains a catalog of common genetic 
variants (single-base variations called 
SNPs) among different populations, 
which has helped scientists identify 
gene variants (or alleles) associated 
with increased risk of diabetes and 
other complex diseases. (Neighboring 
SNPs that are inherited together are 
compiled into haplotypes, hence the 
name HapMap.)
    But such studies can’t detect rare 
disease-related alleles or those that 
reﬂ  ect individual idiosyncrasies. 
What’s more, it is the complex 
interactions between different alleles 
(contributed by each parent), their 
regulatory elements, and a person’s 
environment that determines an 
individual’s physical characteristics 
(also known as phenotype) and 
disease risk. Sequencing both sets of 
chromosomes from an individual—the 
diploid genome—who is willing to 
disclose relevant details about his or 
her personal life offers the opportunity 
to correlate genomic variations with a 
speciﬁ  c phenotype. 
    Toward this end, Venter donated 
his blood for DNA extraction and 
answered questions about his family 
and medical history, personality, and 
physical traits. To assemble Venter’s 
genome (which the researchers called 
“HuRef”), the researchers modiﬁ  ed 
the random shotgun sequencing 
approach that Venter used to produce 
the draft human genome. Brieﬂ  y, 
the shotgun sequencing approach 
randomly shreds genetic material into 
millions of fragments, called “reads,” 
each of which is sequenced and then 
reassembled using a computer (based 
on sequence similarity), which matches 
up overlapping reads and merges them 
into longer sequences. By reﬁ  ning the 
software algorithms of the computer 
assembler (to respect the distinct 
paternal allelic contributions) and 
increasing the number of times they 
repeated the sequencing (to enhance 
data accuracy), the researchers 
decreased the number of gaps in the 
assembly to produce a high-quality 
draft diploid genome sequence. 
Assembling the sequences in the 
proper order and location along the 
chromosomes was guided in part 
by comparing the HuRef sequence 
with the composite human sequence 
assemblies.
     To characterize the extent and 
type of variation in an individual 
genome, the researchers ﬁ  rst identiﬁ  ed 
differences between the maternal 
and paternal chromosomes (that 
is, heterozygous alleles) and then 
compared the HuRef sequence to the 
latest version of the composite human 
genome sequence (known as NCBI 
36). As one would expect, very large 
regions of HuRef matched up with the 
NCBI reference sequence, simplifying 
the task of spotting variation. This 
comparison identiﬁ  ed over 4 million 
variants, 68% of which matched those 
in the central public SNP database 
(dbSNP). Variants came mostly in 
the form of SNPs, but another type 
of genomic alteration—nucleotide 
insertions and deletions (called 
indels)—contributed a surprising 
proportion of observed variation. 
Although indels are far less common 
than SNPs, since they can involve 
several nucleotides, they actually 
account for nearly three-quarters of the 
variant nucleotides detected. 
    Because it’s easier to use haplotypes 
than SNPs to identify disease risk 
in association studies—and would 
likely prove easier in identifying an 
individual’s risk—the researchers used 
a novel computational approach to 
infer haplotypes in the HuRef sequence 
using the identiﬁ  ed DNA variants 
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and the underlying genome assembly 
structure. Their method generated 
haplotypes that were not only “strongly 
consistent” with those found in the 
HapMap data but also extended the 
size of inferred haplotype blocks by 
an order of magnitude, validating the 
accuracy of the approach. 
    What does the researchers’ “initial 
foray into individualized genomics” 
tell us? Genetic variation between the 
chromosome sets inherited from one’s 
parents is far greater than previously 
recognized, when the relatively obscure 
“indels” are taken into account. And 
genetic differences between individuals, 
the researchers suspect, may be 5-fold 
higher than prior estimates. The 
predictive power of individualized 
genomics, they argue, will depend on 
gathering far more genomic data from 
many more individuals. Until then, 
an individual’s genome sequence will 
work best in predicting risk for diseases 
associated with single-gene mutations, 
like Huntington disease or Fragile X 
syndrome. 
    The human genome sequences—
the composite sequences and now 
this individual genome—provide a 
powerful tool for reconstructing the 
molecular agents of human evolution, 
development, physiology, medicine, 
and individuality. No one expects 
to understand what makes a person 
tick by looking at their genome. But 
as researchers amass more and more 
individual genomes annotated with 
personal traits, they’ll be able to test 
the relative contributions of genes 
and environment and provide a more 
informed account of what makes us 
who we are.
    You can explore Venter’s genome 
yourself, by viewing an interactive 
poster of his complete genome 
(doi:10.1371/journal.pbio.0050254.
sd001).
    Levy S, Sutton G, Ng PC, Feuk L, Halpern AL, 
et al. (2007) The diploid genome sequence 
of an individual human. doi:10.1371/journal.
pbio.0050254 
October 2007  |  Volume 5  |  Issue 10  |  e266